{"id":"Z05","lang":"zh","question":"泰合的 BEQIA 美國什麼時候會有審查結果？有沒有 FDA 的確切日期？","answer":[{"text":"泰合公告的 BEQIA 美國 FDA PDUFA 審查完成目標日期是 2027 年 4 月 22 日。","fact_ids":["f1"]},{"text":"公司 2026 年 9 月 7 日發布的新聞稿稱，BEQIA（TAH3311）NDA 資料已確認完整，進入標準審查。","fact_ids":["f2"]}],"facts":[{"id":"f1","claim":"PDUFA Goal Date","value":"2027-04-22","as_of":"2026-09-07","source":"https://www.tahopharma.com/news-detail/132/","quote":"審查完成目標日期（Goal Date）為2027年4月22日"},{"id":"f2","claim":"申請階段","value":"NDA 標準審查","as_of":"2026-09-07","source":"https://www.tahopharma.com/news-detail/132/","quote":"已正式進入標準審查（Standard Review）程序"}],"undisclosed":{"text":"這份公開新聞稿沒有揭露 FDA 最終決定的實際日期與結果，也沒有附上 FDA 來函全文。","source":"https://www.tahopharma.com/news-detail/132/","as_of":"2026-10-22","quote":"獲美國食品藥物管理局（FDA）來函確認申請資料完整","scope":"Only the specific primary documents cited in this card were checked; absence is not a claim about all public disclosures."},"verified_at":"2026-10-22","coverage":"partial","limitations":["目前只能確認公司揭露的目標日期；FDA 原始來函全文查無。"]}